|
|
Recent news from the US Food and Drug Administration.
Click title to see the full article at the FDA
website. For the most up-to-date headlines, check out the FDA
Newsroom. Press announcements from 2004 to 2009 are available through
the FDA
Archive.
FDA
Recalls: FDA posts press releases and other notices of recalls and
market withdrawals from the firms involved as a service to consumers,
the media, and other interested parties. FDA does not endorse either the
product or the company. This site does not contain a complete list of
recalls -
search for recalls at the official FDA site.
| June 30, 2026 - FDA
Approves New Treatment That Uses Donor Immune Cells to Prevent Serious
Complications in Blood Cancer Patients |
| June 29, 2026 - FDA
Selects Seven Participants for PreCheck Pilot Program to Advance U.S.
Drug Manufacturing |
| June 26, 2026 - FDA
Proposes Rule That Would Help Hold Foreign Tobacco Product Manufacturers
Accountable, Protect Public Health |
| June 17, 2026 -
FDA Approves First Single-Dose Generic Treatment for Influenza |
| June 16, 2026 - FDA
Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid
Overdose |
| June 15, 2026 - FDA
Approves New Indication for Tzield (teplizumab) for Certain Pediatric
Patients with Recently Diagnosed Stage 3 Type 1 Diabetes |
| June 12, 2026 - FDA
Clears First Over-the-Counter Continuous Glucose Monitor for Children |
| June 11, 2026 - FDA
Issues Emergency Use Authorization for Generic Over-the-Counter Drug
to Treat New World Screwworm in Dogs and Cats |
| June 9, 2026 - FDA
Expands Sunscreen Options for the First Time in 20 Years |
| June 2, 2026 - FDA
Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for
Patients |
| May 29, 2026 - FDA
Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer
Drugs |
| May 22, 2026 - FDA
Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection |
| May 20, 2026 - FDA
Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday
Products |
| May 12, 2026 - FDA
Finalizes Food Chemical Safety Post-Market Assessment Program, Launches
Reassessment of BHT, ADA |
| May 11, 2026 - FDA
Advances Drug Repurposing to Address Unmet Medical Needs |
|
May 8, 2026 - FDA
Grants Seventh Approval under the National Priority Voucher Pilot
Program
|
| May 8, 2026 - FDA
Issues Guidance to Improve Collection of Pregnancy Safety Data for
Drugs and Biologics |
| May 6, 2026 - FDA
Expands AI Capabilities and Completes Data Platform Consolidation |
| May 6, 2026 - FDA
Launches One-Day Inspectional Assessments to Strengthen and Expand
Oversight |
| May 5, 2026 - FDA
Expands Market Access, Authorizes New ENDS Products |
| May 1, 2026 - FDA
Permits Expanded Access for Investigational Pancreatic Cancer Drug |
|
|
